Group One Trading
AMRX icon

Group One Trading’s Amneal Pharmaceuticals AMRX Stock Holding History

Group One Trading’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-900
Closed -$7.28K – 8337
2025
Q2 		$7.28K Sell
900
-19,400
-96% -$146K ﹤0.01% 6906
2025
Q1 		$170K Buy
20,300
+11,300
+126% +$94.3K ﹤0.01% 4152
2024
Q4 		$71.3K Hold
9,000
– – ﹤0.01% 4796
2024
Q3 		$74.9K Buy
+9,000
New +$70.4K ﹤0.01% 4387
2023
Q1 		– Sell
-38,300
Closed -$76.2K – 7148
2022
Q4 		$76.2K Sell
38,300
-409,900
-91% -$919K ﹤0.01% 4675
2022
Q3 		$905K Sell
448,200
-219,600
-33% -$615K ﹤0.01% 2672
2022
Q2 		$2.12M Buy
667,800
+367,600
+122% +$1.33M ﹤0.01% 1999
2022
Q1 		$1.25M Buy
300,200
+200
+0.1% +$886 ﹤0.01% 2858
2021
Q4 		$1.44M Buy
300,000
+272,400
+987% +$1.36M ﹤0.01% 2959
2021
Q3 		$147K Buy
27,600
+22,700
+463% +$114K ﹤0.01% 5494
2021
Q2 		$25K Sell
4,900
-88,300
-95% -$502K ﹤0.01% 7047
2021
Q1 		$627K Buy
93,200
+91,200
+4,560% +$505K ﹤0.01% 3773
2020
Q4 		$9K Buy
+2,000
New +$8.86K ﹤0.01% 5806
2020
Q2 		– Sell
-18,100
Closed -$63K – 5748
2020
Q1 		$63K Sell
18,100
-35,700
-66% -$151K ﹤0.01% 3576
2019
Q4 		$259K Sell
53,800
-31,500
-37% -$109K ﹤0.01% 2972
2019
Q3 		$247K Buy
85,300
+79,800
+1,451% +$278K ﹤0.01% 2932
2019
Q2 		$39K Buy
5,500
+5,400
+5,400% +$55.2K ﹤0.01% 3893
2019
Q1 		$1K Buy
+100
New +$1.32K ﹤0.01% 4644
2018
Q4 		– Sell
-33,700
Closed -$748K – 4824
2018
Q3 		$748K Hold
33,700
– – 0.01% 1932
2018
Q2 		$553K Buy
+33,700
New +$591K ﹤0.01% 2210

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Group One Trading's AMRX Position: Q3 2025 in Review

Group One Trading sold out of Amneal Pharmaceuticals (AMRX) in Q3 2025, closing a stake of 2,991 shares — an estimated $26.8K sold.

Group One Trading first reported a position in AMRX in Q2 2018 and held it in 19 quarters. The position peaked at $1.56M in Q2 2022. 248 funds tracked by Wall St. Rank hold AMRX as of Q3 2025.

  • Group One Trading reported no remaining Amneal Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 2,991 Amneal Pharmaceuticals shares in Q3 2025, an estimated $26.8K.
  • Group One Trading first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 19 quarters.
  • Group One Trading's Amneal Pharmaceuticals position peaked at $1.56M in Q2 2022.
  • 248 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.